Related Conflict of Interest Policies

Title : Research Conflict of Interest - Disclosure, Review and Management Number : 1362, Version : 12

C. Retention of Documentation 1. BH will maintain all documentation noted in this Policy and all other documentation related to COI indefinitely, unless written permission to destroy/dispose of the documentation is obtained from the COI Official. BH will maintain all records as required by applicable law and regulation. D. Corporate Oversight 1. The BH General Counsel and/or BH Vice President of Ethics & Compliance/Chief Compliance Officer may, through written instruction or directive, vary the application of some or all components of this policy.

V. Procedural Documentation:

A. Form: Study-Specific COI Disclosure Form

VI. Additional Information: A. Email address for submission of Institutional COI Disclosure Form: BHResearchCompliance@bannerhealth.com B. Questions regarding this Policy should be directed to: Conflict of Interest Official Email: BHResearchCompliance@bannerhealth.com Phone: (602) 839-4583

VII. References:

A. 21 Code of Federal Regulations (CFR) Part 50 B. 21 CFR 56 C. 45 CFR 46 D. 45 CFR 164

E. Protecting Patients, Preserving Integrity, Advancing Health: Accelerating the Implementation of COI Policies in Human Subjects Research: A Report of the AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Human Subjects Research (February 2008)

VIII. Other Related Policies/Procedures: A. Policy: Conflict of Interest (#732) B. Policy: Research Conflict of Interest Relating to PHS Grants, Cooperative Agreements & Contracts (#1364) IX. Keywords and Keyword Phrases: A. Conflict of Interest B. COI C. Conflict of Interest Committee D. COIC E. Covered Individual Conflict of Interest F. Financial Conflict of Interest G. FCOI H. Institutional Conflict of Interest I. Institutional Review Board J. IRB

Page 9 of 11